SCHEMBL31685572

SCHEMBL31685572

CN1C(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2N(C)C1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 1/20 0.55
▸ DNMT1 P26358 1/20 0.55
▸ PIM1 P11309 1/20 0.47
▸ CSNK2A2 P19784 1/20 0.47
▸ CSNK2B P67870 1/20 0.47
▸ CSNK2A1 P68400 1/20 0.47
▸ CSNK2A3 Q8NEV1 1/20 0.47
▸ HIF1A Q16665 1/20 0.46
▸ PNP P00491 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ PDE4D Q08499 1/20 0.45
▸ PDE3A Q14432 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ ADA P00813 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31685767 0.86 TYMS (0.45) —
SCHEMBL31685474 0.85 ADRB1 (0.50) ADRB1DNMT1PIM1CSNK2A2CSNK2B
SCHEMBL31685878 0.85 ADRB1 (0.50) ADRB1DNMT1PIM1CSNK2A2CSNK2B
SCHEMBL31685300 0.84 P2RY1 (0.41) ADRB1DNMT1ADORA1
SCHEMBL31685632 0.82 ADRB1 (0.54) ADRB1DNMT1PIM1CSNK2A2CSNK2B
SCHEMBL31685477 0.80 ALDH1A1 (0.53) DNMT1LMNATP53HTTSMN1; SMN2
SCHEMBL31685511 0.77 MEN1 (0.46) DNMT1LMNATP53HTTSMN1; SMN2
SCHEMBL31685292 0.76 PIM1 (0.49) ADRB1DNMT1PIM1CSNK2A2CSNK2B
SCHEMBL31685635 0.75 ADORA1 (0.50) ADORA1
SCHEMBL13329970 0.72 ADRB1 (0.56) ADRB1DNMT1PIM1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE TEAM MEDICAL, LLC 2025-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289840-A1 RNA STABILIZING SUBSTANCES AND METHODS OF USE SYNCRIP, SNRPA, RNASE1 ADRB1 4506/4885DNMT1 3133/4885PIM1 3048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback